Onchocerca volvulus microfilariae avoid complement attack by direct binding of factor H

Journal of Infectious Diseases

Volumn 185, Issue 12, 2002, Pages 1786-1793

  Meri, Taru ^a   Jokiranta, T Sakari ^a   Hellwage, Jens ^b   Bialonski, Alexandra ^c   Zipfel, Peter F ^b,c   Meri, Seppo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HANS KNÖLL INSTITUTE   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ISOTOPE LABELING; MICROFILARIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICROFILARIA; MICROSCOPY, FLUORESCENCE; ONCHOCERCA VOLVULUS; PROTEIN BINDING;

EID: 0037097649     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340649     Document Type: Article

References (46)

1. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control
2. Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa
3. Onchocerciasis
4. Molecular biology and chemistry of the alternative pathway of complement
5. Cellular killing of microfilariae of Onchocerca volvulus: Eosinophil and neutrophil-mediated immune serum-dependent destruction
6. Complement activation by eggs and microfilariae of filarial parasites
7. Neutrophil-mediated killing of Dipetalonema viteae microfilariae: Simultaneous presence of IgE, IgG antibodies and complement is required
8. Complement-mediated adherence of cells to microfilariae of Brugia malayi
9. Control of the amplification convertase of complement by the plasma protein b1H
10. Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein b1H for cleavage of C3b and C4b in solution
11. Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H
12. Binding of complement factor H to loop 5 of porin protein 1A: A molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae
13. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae
14. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H
15. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi
16. Complement evasion by Borrelia burgdorferi: Serum-resistant strains promote C3b inactivation
17. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and factor H
18. Complement evasion by Echinococcus granulosus: Sequestration of host factor H in the hydatid cyst wall
19. Diagnosis and extirpation of nodules in human onchocerciasis
20. Isolation of living adult Onchocerca volvulus from nodules
21. Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: Evidence for multiple interactions between H and surface bound C3b
22. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d
23. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement
24. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H
25. The C-terminus of factor H: Monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins
26. Each of the three binding sites on complement factor H interacts with a distinct site on C3b
27. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen)
28. Interactions of soluble CD59 with the terminal complement complexes: CD59 and C9 compete for a nascent epitope on C8
29. Improved mountant for immunofluorescence preparations
30. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: Binding to the C3d region of C3b and differential regulation by heparin
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Complement resistance of parasites
33. Schistosoma mansoni: Cell-specific expression and secretion of a serine protease during development of cercariae
34. Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59
35. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor
36. A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2
37. Immunohistological studies on macrophages in lymph nodes of onchocerciasis patients after treatment with ivermectin
38. Human complement factor H: Expression of an additional truncated gene product of 43 kDa in human liver
39. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1
40. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H
41. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins
42. Localization of the heparin-binding site on complement factor H
43. Regulation of alternative pathway complement activation by glycosaminoglycans: Specificity of the polyanion binding site on factor H
44. Identification of the second heparin-binding domain in human complement factor H
45. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates
46. OvB20, an Onchocerca volvulus-cloned antigen selected by differential immunoscreening with vaccination serum in a cattle model of onchocerciasis